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Abstract
Background: Milk contains too little arginine for normal growth, but its precursors proline and
glutamine are abundant; the small intestine of rodents and piglets produces arginine from proline
during the suckling period; and parenterally fed premature human neonates frequently suffer from
hypoargininemia. These findings raise the question whether the neonatal human small intestine also
expresses the enzymes that enable the synthesis of arginine from proline and/or glutamine.
Carbamoylphosphate synthetase (CPS), ornithine aminotransferase (OAT), argininosuccinate synthetase
(ASS), arginase-1 (ARG1), arginase-2 (ARG2), and nitric-oxide synthase (NOS) were visualized by
semiquantitative immunohistochemistry in 89 small-intestinal specimens.
Results: Between 23 weeks of gestation and 3 years after birth, CPS- and ASS-protein content in
enterocytes was high and then declined to reach adult levels at 5 years. OAT levels declined more
gradually, whereas ARG-1 was not expressed. ARG-2 expression increased neonatally to adult
levels. Neurons in the enteric plexus strongly expressed ASS, OAT, NOS1 and ARG2, while
varicose nerve fibers in the circular layer of the muscularis propria stained for ASS and NOS1 only.
The endothelium of small arterioles expressed ASS and NOS3, while their smooth-muscle layer
expressed OAT and ARG2.
Conclusion: The human small intestine acquires the potential to produce arginine well before
fetuses become viable outside the uterus. The perinatal human intestine therefore resembles that
of rodents and pigs. Enteral ASS behaves as a typical suckling enzyme because its expression all but
disappears in the putative weaning period of human infants.
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Background
Arginine is a precursor for the synthesis of proteins, creat-
ine, agmatine, and nitric oxide (NO). It further plays an
essential role in ammonia and bicarbonate detoxification,
and stimulates the secretion of growth hormone, prolac-
tin, insulin, and glucagon. Arginine is also a 'condition-
ally essential' amino acid, meaning that endogenous
arginine production covers metabolic requirements in
healthy, unstressed individuals, but becomes an essential
amino acid under conditions of increased need, e.g.
growth or tissue repair, or in catabolic states such as sepsis
and starvation.
In the adult, endogenous arginine biosynthesis is an inter-
organ 'affair': the net production of citrulline occurs
almost exclusively in the enterocytes of the small intestine
[1], also in man [2], but absorption of citrulline from the
circulation and subsequent biosynthesis of arginine can
take place in many tissues [3]. Of these, the cortex of the
kidney provides approximately 20% of whole-body
requirements [4]. In perinatal mice [5,6] and piglets [7-9],
however, all enzymes necessary for arginine biosynthesis
from proline and glutamine (Figure 1) are expressed in
the enterocytes of the small intestine, while ARG1, the
main cytosolic arginine-catabolizing enzyme, is not
detectable prior to weaning [5,6,10]. In agreement, the
small intestine plays a prominent role in net arginine pro-
duction in suckling piglets [11-14]. In rodents, intestinal
expression of the enzymes that synthesize arginine from
citrulline, ASS and argininosuccinate lyase, ceases com-
pletely after weaning [6,15]. In pigs, on the other hand,
net synthesis of arginine declines more gradually and is
still present at 7 weeks of age [16]. It has been speculated
that enteric arginine synthesis is necessary to cover neona-
tal requirements, because mammalian milk is a relatively
poor source of arginine, whereas its precursors proline
and glutamine are abundant [17].
Arginine synthesis from proline or glutamine in the mammalian neonatal gut Figure 1
Arginine synthesis from proline or glutamine in the mammalian neonatal gut. Since arginase-1 is not expressed, 
arginine can either be secreted or metabolized to NO and citrulline. Names of enzymes investigated in this study are indicated 
in italics. P-5-C = pyrroline5-carboxylate synthetase.
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In prematurely born human neonates, hypoargininemia
is frequently observed [18] and hypothesized to predis-
pose such infants to the development of necrotizing ente-
rocolitis [19-21]. Although hypoargininemia in
premature human neonates has been associated with fail-
ing intestinal arginine biosynthesis as found in suckling
rodents and piglets [22], no evidence to support this asso-
ciation exists thus far. To confirm or reject the hypothesis
that the perinatal human gastrointestinal tract resembles
that of rodents or pigs with respect to arginine production,
we studied the developmental changes in the expression
of CPS, OAT and ASS, three key enzymes with a high con-
trol of de novo intestinal synthesis of citrulline and
arginine, and ARG1 and ARG2, the main arginine-cat-
abolizing enzymes in full-thickness and mucosal biopsies
of the human small intestine. The findings demonstrate
that the epithelium of the fetal and neonatal small intes-
tine abundantly expresses CPS (as we reported earlier
[23,24]), OAT and ASS, whereas cytosolic ARG1 is not
detectable. These data show that the perinatal human
intestine resembles that of rodents and, in particular, pigs
with respect to its capacity to produce arginine. We also
show that the expression of the controlling enzyme, ASS,
all but disappears between 3 and 5 years of age, that is, the
putative weaning age of human infants [25]. Finally, we
show that the enteric ganglia and arteriolar endothelium
co-express ASS and the constitutive NO-synthases NOS1
and NOS3, respectively, which both use arginine as sub-
strate for NO synthesis.
Methods
Tissue
A total of 89 samples were included in the study (Table 1).
Formalin-fixed, paraffin-embedded samples originated
from the archives of the Institute of Pathology, University
Hospital Basel, Switzerland, and the Department of
Pathology, AMC, Amsterdam, the Netherlands. Full-thick-
ness duodenal, jejunal and ileal samples were from
infants, who presented with gastroschisis, atresia, meco-
nium ileus or Meckel's diverticulum, whereas the samples
from adults were from patients who underwent surgery
for tumors. Duodenal mucosal biopsies were collected
from patients who underwent endoscopy for various gas-
trointestinal complaints. Furthermore, full-thickness
intestinal samples of 9 fetuses between 14 and 40 gesta-
tional weeks were examined. For each sample, age, gender
and diagnosis were available, but in all other respects, the
samples had been anonymized to avoid patient identifica-
tion. Under this condition, residual tissue could be used
for the research reported here [26]. In addition, approval
has been obtained from the Ethikkommission beider
Basel EKbB, Switzerland, reference number EK 135/08 for
the samples obtained from the Institute of Pathology in
Basel.
Immunohistochemistry
Tissue was fixed in 4% formaldehyde and embedded in
paraffin following standard protocols. 5–7 μm-thick sec-
tions were used. Section thickness does not affect immu-
nohistological staining intensity, since antibodies only
bind to the surface of the sections [27]. As an additional
cautionary measure to avoid staining differences due to
differences in fixation, we used neuronal staining as an
internal reference. Sections were deparaffinized, hydrated
in graded ethanols, and heated in 10 mM sodium citrate
(pH 6.0) to 98°C for 10 minutes followed by 90 minutes
cool-down to room-temperature to retrieve antigens. After
this treatment, endogenous alkaline phosphatases are
denatured and no longer active. Remaining activity of
endogenous peroxidases (catalase) was inactivated where
appropriate by exposing the sections for 30 min to 3%
H2O2 in PBS. After blocking with TENG-T (10 mM Tris pH
7.4, 5 mM EDTA, 150 mM NaCl, 0.25% gelatin, 0.05%
Tween-20) plus 10% goat serum, sections were incubated
overnight at room temperature with the first antibody,
washed in 0.5 M Na-acetate and incubated with an alka-
line phosphatase- or peroxidase-coupled secondary anti-
body for 60 to 90 minutes. Sections were developed with
Table 1: Human gut samples
Group Age # of samples Sample origin Resections Biopsies
SI D J I
1 -182/-3 days 9 7 2 9 0
2 1 – 11 days 14 1 4 3 6 14 0
3 6 wks – 1 yr 10 4 1 5 9 1
4 1,5 – 3 yrs 12 2 7 3 5 7
5 3 – 5 yrs 16* 15 3 0 16
6 5 – 7 yrs 18* 16 5 2 16
7 14 – 22 yrs 5 1 4 4 1
8 50 – 80 yrs 5 4 1 5 0
The table shows the number of samples that were analyzed per age group, the topographic location of the samples (SI = small intestine, D = 
duodenum, J = jejunum, I = ileum), and whether they were mucosal biopsies and full-thickness resections. For age groups 5 and 6, parallel samples 
were available from two different regions of the small intestine. These were used to check for the effect of location on enzyme expression, but only 
one sample per patient was taken into account for the statistical analysis. This is the reason for the discrepancy between "# of samples" (marked by 
an asterisk) and the sum of all samples listed under "Sample origin".BMC Developmental Biology 2008, 8:107 http://www.biomedcentral.com/1471-213X/8/107
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NBT/BCIP (alkaline phosphatase; Roche) or DAB (perox-
idase; Sigma). An incubation without primary antibody
served as negative control for all incubations [see Addi-
tional file 1]. This protocol allows semi-quantitative
assessment on sections [28].
The following rabbit primary antibodies were used: ASS
(1:10,000) [15]; ARG1 and ARG2 (1:500, sc-20150 and
1:400, sc-20151, respectively, Santa Cruz Biotechnology,
California); CPS (1:500) [29]; OAT (1:1,500) [30]. Anti-
body binding was visualized with alkaline phosphatase-
coupled goat anti-rabbit IgG (1:200, Sigma A-3687).
NOS1 and NOS3 were detected with mouse monoclonal
antibodies (NOS1 1:400, IgG2a clone #16; NOS3 1:200,
IgG1 clone #3, BD Transduction Laboratories) and visual-
ized with an alkaline phosphatase-coupled goat anti-
mouse secondary antibody (1:200, Sigma A3562) and a
peroxidase-coupled rabbit anti-mouse secondary anti-
body (1:200, Sigma A3682), respectively. Single NOS1
positive cells in the lamina propria were further character-
ized by staining for the presence of CD68 (monocytes/
macrophages 1:200, Dako M0876), CD3 (T-lymphocytes
1:600, Dako A0452), CD20 (B-cells 1:500, Dako M0755
clone L26), CD1A (dendritic cells 1:10, Neomarkers MS-
1856-P1), and CD138 (plasma cells 1:100, Dako M7228
clone MI15).
Western Blotting
Villus epithelium was scraped off fresh duodenal resec-
tion material and lysed in SDS-PAGE sample buffer. After
separation of samples on 10% SDS-polyacrylamide gels
and blotting to PVDF membranes, proteins were visual-
ized with antisera to ARG1 (1:200); ARG2 (1:500); NOS1
(1:2500); NOS3 (1:2500); α-SMA, (1:1000). The appro-
priate secondary horse-radish peroxidase-coupled anti-
bodies were used at a dilution of 1:10,000. The signal was
amplified using the chemiluminescent Super Signal West
Pico reagent (Pierce, Perbio Science, The Netherlands)
and pictures were taken with a LAS3000 imaging system
(Fujifilm). α-smooth muscle actin was used to determine
the contribution of the submucosa to the scrapings.
Evaluation of samples
Sections were scored for staining intensity in random
sequence by 3 investigators with the readers of the slides
blinded. Villi and crypts were scored separately. The inten-
sity of ASS, OAT and ARG2 staining in enterocytes was
expressed on a scale of 0–3 (0: absent; 1: weak; 2: interme-
diate; and 3: strong expression) relative to their expression
in the ganglia of the myenteric plexus, which always con-
tained both strongly and weakly positive neurons for ASS,
OAT, and ARG2. Expression in the strongly staining neu-
rons was set at 3. Samples without ganglia (mucosal biop-
sies from the duodenum) were compared to
simultaneously stained samples that did contain ganglia
to assign an intensity score from 0 to 3. Because CPS
expression in the small intestine is restricted to entero-
cytes, all samples were stained simultaneously and then
compared to each other using the same scale of 0–3 as
described above. There was never more than one scoring
unit difference between the 3 investigators.
Statistics
We used box-plots to visualize distribution and develop-
mental changes of enzyme expression in enterocytes.
Two-way analysis of variance (ANOVA) on rank-trans-
formed data showed age-group and structure (crypt or vil-
lus) differences as well as age and structure interactions
per enzyme. Sex (male or female) was not a factor associ-
ated with differences in enzyme expression. To pin-point
which age-groups and crypts or villi differed, non-para-
metric one-way ANOVA (Kruskal-Wallis) tests were per-
formed between age-groups per structure. Multiple
comparison (Mann-Whitney) tests between structures per
age-group were performed, when the null hypothesis was
rejected. P values were considered significant if < 0.05.
Results
The earliest sample studied was a small intestine of a 14-
week-old fetus, whereas the oldest sample was from a 79
year-old patient. Most of the samples examined were from
patients younger than 7 years. At 14 weeks of gestation, all
structural components of the epithelium, enteric nerves,
and smooth muscle layers have formed [31,32]. Speci-
mens were from the duodenum, jejunum, or ileum, with
the majority of samples originating from the duodenum
and ileum (Table 1). From 4 patients (age groups 5 and 6;
3–7 years), parallel samples of duodenum and ileum were
available. In these samples, no differences in staining
intensities of the enzymes investigated were observed
between the proximal and distal small intestine or
between males and females. For these 2 reasons, we felt
justified to pool the samples of one age group. Of neces-
sity, the studied specimens included both mucosal biop-
sies and full-thickness specimens, were all obtained to
diagnose gastrointestinal conditions, and were contrib-
uted by different institutions. Because the gastrointestinal
conditions were diverse in nature and the observed
changes in enzyme levels concordant, our conclusions
reflect developmental biology rather than pathology.
Based on the staining patterns in these samples, we
describe the developmental changes in the expression of
arginine-synthesizing enzymes CPS, ASS and OAT, and
the arginine-metabolizing enzymes ARG1, ARG2, NOS1
and NOS3 in the enterocytes of the small intestine.
Expression of CPS, ASS, OAT, ARG, NOS1 and NOS3 in 
enterocytes
Carbamoylphosphate synthetase (Figures 2A and 3; [see also 
Additional files 2 and 3])
CPS protein was exclusively found in the enterocytes.
Prior to birth (group 1), CPS expression was uniformlyBMC Developmental Biology 2008, 8:107 http://www.biomedcentral.com/1471-213X/8/107
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high in the enterocytes of both crypts and villi (Figure 3A).
Between birth and 3 years of age (groups 2–4), CPS
expression did not change significantly in the enterocytes
on the villi, but declined thereafter to reach adult levels by
5 years of age (difference in villous expression between
groups 1–4 vs. groups 5–8: P ≤ 0.0001). Between birth
and 1 year of age, expression was higher in the villus than
in the crypt enterocytes (P < 0.005; Figure 3B [see Addi-
tional file 2]). Thereafter, staining differences between
villi and crypts disappeared again (Figure 3C–F). No
expression of CPS was found in the epithelium of Brun-
ner's glands [see Additional file 3].
Ornithine aminotransferase (Figures 2B and 4; [see also Additional 
files 2 and 3])
OAT expression in the epithelium was uniform prior to
birth. The youngest samples that could be investigated
were from gestational week 23 (Figure 4A). Fetal expres-
sion was significantly higher in both crypts and villi than
in the other age groups (P ≤ 0.004). Directly after birth,
OAT expression remained strong in the epithelium cover-
ing the villi, but declined in the crypts (P ≤ 0.017), with
the exception of age group 4 (1, 5-3 years). In some prep-
arations, expression was stronger at the base of the villi,
just above the crypts (Figure 4B, D). Above 40 years of age,
OAT expression again resembled the fetal pattern, with
crypt and villus enterocytes expressing OAT almost evenly
albeit at a lower level (Figure 4E). The epithelium of Brun-
ner's glands did not express OAT [see Additional file 3].
Argininosuccinate synthetase (Figures 2C and 5; [see also Additional 
files 2 and 3])
With the exception of the age groups 5 and 6 (3–7 years),
ASS protein accumulated to a much higher concentration
in the enterocytes on the villi than in the crypts (P <
0.014), especially before 3 years of age (P < 0.004). This
pattern was already found in gestational week 14, where
epithelial expression of ASS was still low (Figure 5A).
From week 23 onward, expression in the villus epithelium
was intermediate to strong. ASS expression remained high
during the first postnatal year (groups 2 and 3 vs. groups
5–8, P < 0.0001), and then declined via an intermediate
score between 1.5 and 3 years (group 4) to a near-absent
score between 3 and 5 years (group 5). ASS expression in
the crypts slowly declined after birth to become undetect-
able after 3 years of age (Figure 5B–F; [see also Additional
file 2]) (Groups 1–4 vs. groups 5–8 in a multiple compar-
ison of groups: P < 0.0001). As long as ASS expression was
high (i.e. in the first 3 years), ASS protein was present
throughout the enterocytes (Figure 5A–C), but in children
and young adults, it gradually became concentrated at the
basal side of the enterocytes (Figure 5D–F). No expression
of ASS was found in the epithelium of Brunner's glands
[see Additional file 3].
Developmental changes in expression of CPS, ASS, OAT and  ARG2 in enterocytes of the small intestine Figure 2
Developmental changes in expression of CPS, ASS, 
OAT and ARG2 in enterocytes of the small intestine. 
Sections represented in the top three panels (CPS, ASS and 
OAT) were stained simultaneously, whereas a subset of the 
samples with 2–4 individual sections per age group was 
stained later and is represented in the bottom panel (ARG2). 
The staining intensities were graded on a scale of 0 to 3. 
Medians of all observations of each age-group are indicated 
by diamonds and are plotted for villi (pink) and crypts (blue) 
separately. The vertical bars represent the first and third 
quartiles of each age group. When not drawn, the quartile 
coincides with the median. Age groups are: 1: fetus (14th – 
39th week of pregnancy); 2: 1–11 postnatal days; 3: 42–365 
days; 4: 1.5–3 years; 5: 3–5 years; 6: 5–7 years; 7: 14–22 
years; 8: 39–79 years; for details, consult Table 1. For CPS 
and ASS, expression in groups 1–4 was significantly higher 
than in groups 5–8, whereas for OAT, expression in prenatal 
group1 was higher than in the postnatal groups (for details, 
see main text). Significant differences in expression between 
villus and crypt enterocytes are indicated by an asterisk if P ≤ 
0.005, a "#" if P ≤ 0.017, and a "+" if P ≤ 0.04. Significant dif-
ferences between age groups are described in the Results 
section.BMC Developmental Biology 2008, 8:107 http://www.biomedcentral.com/1471-213X/8/107
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Arginase-1 (Figure 6A)
ARG1, the major arginine-catabolizing enzyme, was not
detectable immunohistochemically in the epithelium of
the small intestine at any of the ages investigated. West-
ern-blot analysis of samples from an adult duodenum
(age: 60 years) were also negative for ARG1, confirming
the immunohistochemical findings.
Arginase-2 (Figures 2D, 6A, and 7)
Western blots of the adult duodenum showed, instead,
expression of the mitochondrial isoform of arginase
(Figure 6A). We therefore investigated expression of
ARG2 in a subset of samples (2–4/group) from all age-
groups analyzed for ASS, CPS and OAT expression. ARG2
expression in fetal enterocytes was very weak (Figure 7A)
or absent, but in neonates and all older age groups,
expression was significantly higher (P < 0.02). After
birth, protein expression in enterocytes was stronger on
the villi than in the crypts (Figure 7B–F; P < 0.0001 for
all groups in a multiple comparison; due to the relatively
small sample size this difference was not significant for
all individual groups).
Developmental changes in expression of carbamoylphosphate synthetase in human small intestine Figure 3
Developmental changes in expression of carbamoylphosphate synthetase in human small intestine. Panel A: ges-
tational week 14; panel B: jejunum of a 3-day-old term male neonate; panel C: ileum of a 3-year-old male toddler; panel D: 
ileum of a 6-year-old male child; panel E: ileum of a 22-year-old female patient; panel F: ileum of a 70-year-old female patient. 
Scale bar: 100 μm.BMC Developmental Biology 2008, 8:107 http://www.biomedcentral.com/1471-213X/8/107
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NOS1 (Figure 6A)
Over-staining of sections with NOS1 yielded weak epithe-
lial staining. Enterocytes of the human small intestine
express high levels of NOS1 mRNA, but protein was not
detected [33]. In agreement, a Western blot of a protein
extract from villus epithelium did not show staining for
NOS1, demonstrating that the observed staining of the
sections was due to non-specific antibody binding.
NOS3 (Figure 6A)
We found weakly positive staining of villus epithelium
with our NOS3 antibody. NOS3 mRNA is not expressed in
enterocytes [33]. We, therefore, incubated a Western blot
of a protein extract from epithelial cells with the same
antibody as used for immunohistochemistry, but no
immunoreactivity with NOS3 could be demonstrated,
showing that the observed staining of the sections was due
to non-specific antibody binding.
Localization of enzymes involved in arginine biosynthesis (Figure 8)
Serial sections of the distal duodenum at postnatal day 1
demonstrated that the highest expression of CPS, ASS, and
OAT was found in the enterocytes covering the villi (Fig-
ure 8A, D, G). CPS-, OAT-, and ASS-positive enterocytes
did not express ARG1 (not shown). The positive staining
of the ARG1-rich lysed erythrocytes [34] inside vessels
served as an internal positive control for the absence of
ARG1 staining in enterocytes. ASS was also expressed in
Developmental changes in expression of ornithine aminotransferase in human small intestine Figure 4
Developmental changes in expression of ornithine aminotransferase in human small intestine. Panel A: gesta-
tional week 23; panel B: jejunum of a 3-day-old term male neonate; panel C: ileum of a 3-year-old male toddler; panel D: ileum 
of a 6-year-old male child; panel E: ileum of a 70-year-old female patient. Scale bar: 100 μm.BMC Developmental Biology 2008, 8:107 http://www.biomedcentral.com/1471-213X/8/107
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the endothelium of the small arteries (Figure 8E, arrow),
while OAT was present in the smooth muscle wall of these
vessels (Figure 8H, white arrowhead). In addition, ASS
and OAT were expressed in the ganglia of the myenteric
plexus (Figure 8F, I, arrows). Only ASS was prominent in
the varicose nerves of the circular muscle layer (Figure 8F,
arrow head) and, to a lesser extent, in those of the longi-
tudinal muscle layer.
Expression of enzymes in enteric nerves (Figure 6B)
Single neurons in the ganglia of both the myenteric and
the submucosal plexus stained very strongly for ASS, OAT,
ARG2, and NOS1, whereas other neurons in the same
ganglion stained weaker or not at all. The strongly OAT-
positive neurons were also positive for ASS and NOS1
(Figure 6B, black arrows), but some ganglia that were pos-
itive for both NOS1 and ASS did not express OAT (Figure
6B, white arrows). ASS- and NOS1-negative neuronal
bodies were not observed in ganglia. Considerable stain-
ing of varicose nerve fibers for ASS and NOS1, but not for
OAT, was observed in the circular and, to a lesser extent,
the longitudinal smooth-muscle layer (Figures 6B and
8F). Positive staining for ASS of single neurons in mye-
nteric ganglia was already found in gestational week 14
Developmental changes in expression of argininosuccinate synthetase in human small intestine Figure 5
Developmental changes in expression of argininosuccinate synthetase in human small intestine. Panel A: gesta-
tional week 14; panel B: jejunum of a 3-day-old term male neonate; panel C: ileum of a 3-year-old male toddler; panel D: ileum 
of a 6-year-old male child; panel E: ileum of a 22-year-old female patient; panel F: ileum of a 70-year-old female patient. Arrows 
in panel A indicate ASS-positive neurons in the myenteric plexus. Scale bar: 100 μm.BMC Developmental Biology 2008, 8:107 http://www.biomedcentral.com/1471-213X/8/107
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Expression of ASS, ARG and NOS in villus epithelium and neurons Figure 6
Expression of ASS, ARG and NOS in villus epithelium and neurons. Panel A: 40 μg of protein isolated from small-
intestinal scrapings of a 60-year-old patient were loaded per lane (left column). Positive controls (right column) included 25 μg 
of human liver extract for ARG1, NOS1 and α-SMA, 25 μg of human kidney extract for ARG2, and 25 μg of mouse brain 
extract for NOS3. Absence of ARG1, NOS1 and NOS3 expression in the adult small-intestinal enterocytes is demonstrated. 
The density of the ARG2 band is approx. 10% of that in kidney. Panel B: Serial sections (5 μm) of the ileal myenteric plexus of 
a 6-year-old male child were stained for ASS, NOS1, and OAT. Note colocalization of ASS, NOS1, and OAT in intensely stain-
ing neurons (black arrows). Also note OAT-negative ganglia (white arrows). Another section of the same specimen was stained 
for ARG2. Scale bar: 100 μm.BMC Developmental Biology 2008, 8:107 http://www.biomedcentral.com/1471-213X/8/107
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(Figure 5A, arrows), whereas NOS1 (data not shown) and
ARG2 were detectable in gestational week 23 (Figure 7A,
arrows). ASS, OAT, and ARG2 expression was also found
in ganglia of the outer and inner submucosal plexus (Fig-
ures 6B and 7F). The neurons of the myenteric plexus
stained stronger than those of the submucosal plexus,
except those positive for ARG2, which stained equally
strong in both.
Expression of enzymes in the wall of intestinal vessels
The endothelium of the small arterioles in the submucosa
and serosa always stained positive for the presence of ASS
(Figure 8E, arrow) and NOS3, but that of the larger arter-
ies, veins and lymph vessels was negative for both
enzymes. After birth, OAT and ARG2 expression was
demonstrable in the smooth-muscle cell layer of arterioles
(Figures 7F). No expression was found in the smooth-
muscle cell layer of veins.
Expression of enzymes elsewhere in the intestine
Single cells in the lamina propria that were strongly posi-
tive for NOS1 were also positive for CD68, a marker for
macrophages, but not for CD3, CD20, CD138, or CD1A
(lymphocytes and dendritic cells (not shown). Germinal
Developmental changes in expression of arginase-2 in human small intestine Figure 7
Developmental changes in expression of arginase-2 in human small intestine. Panel A: gestational week 23; arrows 
indicate positive neurons in submucosal and myenteric plexus; panel B: jejunum of a 3-day-old term male neonate; panel C: 
ileum of a 3-year-old male toddler; panel D: ileum of a 6-year-old male child; panel E: ileum of a 22-year-old female patient; 
panel F: ileum of a 70-year-old female patient; the white arrow shows staining of a submucosal ganglion, the black arrows indi-
cate staining of smooth muscle cells in the wall of arterioles. Scale bar: 100 μm.BMC Developmental Biology 2008, 8:107 http://www.biomedcentral.com/1471-213X/8/107
Page 11 of 15
(page number not for citation purposes)
centers within lymphocyte aggregates also stained positive
for NOS1 (not shown).
Discussion
The main result of this study is the observation that the epi-
thelium of the perinatal human small intestine expresses
the enzymes that exert control over the biosynthesis of
arginine from proline, bicarbonate, and ammonia, viz.
CPS, OAT and ASS (See Figure 1), and that the major
arginine-degrading enzyme ARG1 is absent during that
period. We deduced this conclusion from an enzyme-histo-
chemical analysis of 79 specimens less than 8 years old.
The human small intestine expresses key enzymes of 
arginine synthesis at midgestation
Although the developmental appearance of CPS, OAT,
and ASS in the enterocytes of the piglet and rodent small
intestine has been reported [6-9,35-38], such information
was only incompletely available for the human small
intestine. CPS expression in the human small intestine
starts as early as the 8th week of gestation [23,24]. Accord-
ingly, CPS was expressed in the enterocytes of all our sam-
ples. To our knowledge, OAT expression in human
enterocytes has not yet been reported, but its develop-
mental profile resembles that of CPS, ornithine car-
Expression of enzymes involved in arginine synthesis in human small intestine at postnatal day 1 Figure 8
Expression of enzymes involved in arginine synthesis in human small intestine at postnatal day 1. Serial sections 
of the distal duodenum of a 1-day-old female neonate. Panels A-C show the expression of CPS; panels D-F: ASS; and panels G-
I: OAT. Endothelial expression of ASS in panel E is indicated by block arrows, while OAT expression in the smooth muscle 
layer of the same vessels is indicated by a white arrowhead (panel H). Panels C, F and I show the muscularis propria with the 
inner circular and outer longitudinal layer. Myenteric ganglia are indicated by black arrows in panels F and I. Varicose nerves in 
the circular muscle layer are indicated by an arrowhead in panel F. Scale bar: 100 μm.BMC Developmental Biology 2008, 8:107 http://www.biomedcentral.com/1471-213X/8/107
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bamoyltransferase and pyrroline-5-carboxylate reductase
in fetal piglets [37]. In agreement, OAT was, like CPS,
expressed in the enterocytes of all our samples. ASS,
finally, is expressed in Caco2 cells [39], but its expression
in normal human small intestinal enterocytes has not yet
been reported. ASS differed from CPS and OAT in that its
expression declined profoundly between 3 and 5 years of
age (Figure 2). The time course in ASS expression in the
postnatal human gut resembles that in piglets, which
declines towards weaning and then rises again [10]. In
rodents, on the other hand, ASS expression disappears
completely at weaning [6,40]. Concurrent with the devel-
opmental decline in ASS expression, its homogeneous
cytosolic distribution changed to one that is restricted to
the basal side of the enterocytes (Figure 5E, F). Asymmet-
ric localization of proteins in enterocytes has been previ-
ously described as a consequence of mRNA sorting [41],
but a change in enzyme localization during late postnatal
development has, to our knowledge, not yet been demon-
strated.
The crypt-villus gradient of postnatal CPS and ASS expres-
sion in the suckling human intestine resembles that in
piglets (our unpublished observations), but markedly dif-
fers from that in rodents. In both rats and mice [5,6], ASS
expression is confined to the enterocytes occupying the
apical half of the villi, whereas CPS is expressed in all ente-
rocytes. This expression pattern suggested to us that the
basal enterocytes synthesized citrulline, whereas the api-
cal enterocytes synthesized arginine [6]. A possible expla-
nation for this spatial separation of cells capable to
produce citrulline only and cells also capable of arginine
production is that the small-intestinal enterocytes are the
only cells in the body that can synthesize citrulline and
that this citrulline is necessary as substrate for arginine
synthesis elsewhere, e.g. the kidney and the endothelium.
Apparently, such a zonation of arginine metabolism is not
necessary in newborn pigs and humans.
The net production of ornithine by the small intestine is a
prerequisite for citrulline and arginine biosynthesis [42].
The severe deficiency of circulating ornithine and arginine
that develops in neonates lacking OAT [38,43] demon-
strates that, in the neonatal intestine, OAT indeed serves to
produce ornithine. Citrulline is exported from the mito-
chondria in exchange for ornithine via the ornithine carrier
ORNT. Accordingly, the ORNT1 isoform is expressed at ele-
vated levels in the small intestine of the mouse during the
suckling period [44]. However, the relatively high expres-
sion of ARG2, the mitochondrial isoform of arginase, in the
neonatal and adult human small intestine could poten-
tially nullify the cytosolic synthesis of arginine (in the
mouse small intestine, ARG2 becomes only expressed at
weaning [5,6]). Extensive degradation of cytosolic arginine
due to import into the mitochondria is, nevertheless,
unlikely, because the affinity of arginine for the ORNT car-
rier is ~10-fold lower than that of ornithine [45].
Together, our findings indicate that the human fetal intes-
tine has acquired the potential to produce arginine at 23
weeks of gestation and probably as early as 14 weeks, that
is, well before fetuses become viable outside the uterus.
Furthermore, NOS1, NOS3 and their downstream target
soluble guanylate cyclase (not shown) were expressed at
term levels in fetuses of ~23 weeks of pregnancy. This
indicates that at this time in gestation the fetus not only
has the potential to synthesize arginine, but also to use it
for NO and cyclic GMP production. Hypoargininemia,
nevertheless, often develops in preterm infants, in partic-
ular if they are maintained on total parenteral nutrition
[5,6,15], and appears to predispose them to the respira-
tory distress syndrome [46] and necrotizing enterocolitis
[19,20]. The hyperammonemia that frequently accompa-
nies hypoargininemia in preterms responds to intrave-
nous arginine supplementation [18], which indicates that
endogenous arginine biosynthesis is deficient. The strong
association with parenteral nutrition points to the intes-
tines and indicates that the intestines only produce
arginine if substrate is supplied from the intestinal lumen,
as was shown for the newborn piglet [11,12].
Intestinal neurons and arterioles express key enzymes of 
arginine synthesis
The neurons of the myenteric plexus abundantly express
OAT, ASS, and NOS1. Since the neurons do not express
CPS and, therefore, cannot synthesize citrulline from
ornithine, OAT most likely functions to produce gluta-
mate, while ASS probably functions to (re-)synthesize
arginine from citrulline [47]. It is conceivable that these
neurons require under certain conditions additional
arginine (synthesized by enterocytes) above their endog-
enous production. Such metabolic cooperation has been
demonstrated for the intestinal sphincters: neurons in
these sphincters can resynthesize arginine from citrulline,
but become dependent on external arginine during pro-
longed activity [48]. The expression pattern of soluble
guanylate cyclase (not shown) demonstrated that there
are many target cells for the NO produced by the neurons
of the myenteric plexus. In this respect, the inner, circular
layer of the muscularis propria differed markedly from the
outer, longitudinal layer both by the far more abundant
distribution of ASS- and NOS1-positive nerve fibres and
its much stronger expression of soluble guanylate cyclase
(not shown). The much stronger immunoreactivity for
NOS1 of the nerve fibers in the circular muscle has been
described [49]. Although nerve cell content and density of
the NOS-positive ganglia of the myenteric plexus [49-51]
markedly declines in the peri- and postnatal period, this
structural difference between both layers of the muscularis
propria is maintained throughout development.BMC Developmental Biology 2008, 8:107 http://www.biomedcentral.com/1471-213X/8/107
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The constantly fed state of the neonatal small intestine
causes absorptive hyperemia, that is, a high intestinal
blood flow and a low intestinal vessel resistance [52]. NO
production in the vessel wall is the main determinant of
this vascular relaxation [53], in particular during the suck-
ling period [54]. Since neonatal hypoargininemia is
closely associated with the risk to develop necrotizing
enterocolitis, a disease of the intestinal vessels [55], we
speculate that arginine biosynthesis in both the entero-
cytes and the endothelial cells of the small vessels of the
intestinal submucosa is necessary to support this hypere-
mic state and to protect the neonatal intestine from
ischemia. Unfortunately, only one intervention trial [56]
without a conclusive outcome [57] has tested the pre-
dicted beneficial effect of arginine supplementation to
preterm neonates thus far. Although arteries of the 1st to
2nd order (out of 4 size categories) are considered to be the
major sites of resistance and blood flow regulation of the
gut [58], we did not observe ASS and NOS3 expression in
the endothelium of 1st order (largest) arteries. Further-
more, the downstream target of NO, soluble guanylate
cyclase, was found in the smooth-muscle layer of arteri-
oles only (not shown), suggesting that these 2nd order ves-
sels materially contribute to the peripheral vascular
resistance in the gut. A recent study showed a deficiency in
NO production but not in NOS3 expression as judged by
immunohistochemistry of intestinal arterioles of patients
with NEC [59], supporting our hypothesis that NOS sub-
strate deficiency plays a role in intestinal ischemia. In
addition to NO production, other factors are involved in
neonatal vascular dysfunction, such as the pro-inflamma-
tory cytokine IL-1β and endothelin-1 [60], but their effects
are mediated at least in part via a blunting of NOS3-medi-
ated NO production.
The decline of arginine-synthesizing enzymes in 
enterocytes and "weaning"
The age-dependent postnatal decline in the expression of
ASS in the enterocytes of the human small intestine is
most pronounced between 3 and 5 years of age. The time
course in ASS expression in the developing human gut
resembles that in piglets, where activity is highest during
the suckling period, declines to low levels around wean-
ing (under natural conditions occurring at 12–15 weeks
[61]) and then rises again [10]. In rodents, on the other
hand, ASS expression disappears completely at weaning
[5,6,15]. In humans, approximately 6 months of age is
considered to be an optimal time point for weaning, but
the natural weaning age for humans may be as late as 2.5–
3 years [25]. The prominent reduction of ASS expression
that we observed after three years of age, therefore, coin-
cides with this assumed natural weaning age.
There is a remarkable similarity in the developmental
timing of the decline in expression of ASS and lactase-
phlorizin hydrolase (hereafter called lactase), another
small-intestinal enzyme that is closely associated with
breast-feeding. In rodents, lactase expression declines
to undetectable levels at weaning [62], whereas in pig-
lets, the decline occurs more gradually during the first
8–16 weeks of life [63]. In lactase-nonpersistent
humans, lactase activity begins to decline between 2
and 3 years [64]. The temporal coincidence of the intes-
tinal capacity to digest lactose and to produce arginine
does support a relation to milk as the main source of
food and underscores the notion that mammalian milk
does not contain enough arginine to support rapid
postnatal growth [17], so that intestinal arginine syn-
thesis is necessary. Although we did find low levels of
ASS in adult intestine, it was recently reported that the
human intestine (age range 37–69 years) does not pro-
duce arginine [65]. This finding does not exclude a role
for local arginine synthesis in e.g. neurons and
endothelial cells that is directly coupled to NO produc-
tion within the same cell.
Conclusion
Our data show that CPS, ASS, and OAT expression is
strong in the enterocytes of fetuses, neonates, infants and
toddlers. Humans, therefore, resemble other mammals in
that the enterocytes of their small intestine are major pro-
ducers of arginine during the suckling period. Although
the relative deficiency of arginine in milk seems to under-
lie this temporary function of the gut, the intestinal or sys-
temic functions that require the arginine that is produced
in the gut remain to be delineated. We submit that relaxa-
tion of the circular smooth muscle layer of the muscularis
propria [49,66] and that of the intestinal arterioles [54]
stand out in this respect.
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